TCL Archive In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three March 12, 1976
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers June 28, 1991
TCL Archive Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs September 7, 1990
TCL Archive Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss June 5, 1981
